Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of CUX2 protein | affects expression | 20106945
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone results in decreased expression of CUX2 mRNA | decreases expression | 17023530
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of CUX2 mRNA | decreases expression | 20106945
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of CUX2 mRNA | decreases expression | 20106945
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of CUX2 mRNA | affects cotreatment|increases expression | 17404688
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of CUX2 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CUX2 mRNA | affects cotreatment|increases expression | 17942748
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of CUX2 mRNA | increases expression | 12057914
|
D009151 |
Mustard Gas |
Mustard Gas results in increased expression of CUX2 mRNA | increases expression | 15674843
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CUX2 mRNA | affects binding|increases activity|increases expression | 19710929
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of CUX2 mRNA | affects cotreatment|increases expression | 17404688
|
D011374 |
Progesterone |
Progesterone results in decreased expression of CUX2 mRNA | decreases expression | 18070364
|
D011374 |
Progesterone |
Progesterone results in increased expression of CUX2 mRNA | increases expression | 17404688
|
D013629 |
Tamoxifen |
Tamoxifen results in increased expression of CUX2 mRNA | increases expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CUX2 mRNA | decreases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CUX2 mRNA | affects cotreatment|increases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.72 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.00 | 15322242 11752688 14514962 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.12 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
9.44 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
9.44 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
7.15 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
7.15 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
7.15 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.71 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.42 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.42 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.21 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.60 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.73 | 15885639 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
2.74 | 10378619 |
MESH:D001768 |
Blister |
|
Mustard Gas |
5.31 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.14 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.14 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.51 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.40 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.35 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.35 | 12948864 17261762 17289903 16675129 17018787 18497071 14630087 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.35 | 15562024 16175315 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.35 | 15565566 17049068 19103187 19066611 19155303 19200415 19221464 20859285 16202921 17440819 19289846 19244106 18629630 16818667 20544844 21152245 18425577 18821012 19142967 18997820 20135344 18984771 19115204 20065188 15668708 16273361 18855134 16873071 11161223 17242785 18351453 20005174 19189210 19059307 17893378 19487384 18815881 17261762 19410462 19189212 20390343 21138602 19011961 19084267 19288272 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.35 | 20435547 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
5.31 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
5.15 | 17687719 10378619 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.62 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.64 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.68 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.68 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
4.68 | 16924424 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.08 | 20419170 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.72 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 18670907 18850075 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.82 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.82 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
13.82 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
13.82 | 17681005 17333356 17110522 15861022 16919318 11677210 16105132 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
13.82 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.14 | 8697196 12621046 15668235 15340226 16354765 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 15322242 20055451 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.50 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.47 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
9.17 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
9.17 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.63 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.56 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.84 | 11462148 |
MESH:D004487 |
Edema |
|
Mustard Gas |
12.07 | 11402378 9260866 11428631 11428647 |
MESH:D004487 |
Edema |
|
pirinixic acid |
12.07 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
12.07 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
16.09 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
16.09 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
16.09 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.62 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.62 | 19155303 17893378 20544844 16202921 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
9.28 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.28 | 10568697 9294722 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.55 | 15328337 17637181 15821434 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
5.31 | 9357497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.03 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
19.68 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
19.68 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
19.68 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
19.68 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.30 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
4.12 | 9205823 11852909 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.68 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.34 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.95 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.95 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.37 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.63 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.63 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.60 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.58 | 15720958 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.49 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.73 | 16221962 18467677 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.73 | 16120746 12621046 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.21 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.93 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 16959395 16354765 8697196 18606429 15340226 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.29 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.07 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.07 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.95 | 16945680 16569931 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.54 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.58 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.56 | 17937319 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
16.47 | 9205823 17963957 12878042 17255318 17237260 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
16.47 | 11428631 8975870 11402378 9260866 16001271 11428620 11428647 17524151 9357497 |
MESH:D007249 |
Inflammation |
|
Progesterone |
16.47 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
16.47 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
16.47 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.43 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.43 | 16306350 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.75 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.62 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.14 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.14 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.92 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
12.92 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
12.92 | 18625569 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.85 | 15821434 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.23 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.86 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
6.86 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.86 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
6.86 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.86 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
14.64 | 9163691 18177683 15890375 2125692 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
14.64 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
14.64 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
14.64 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.64 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
6.03 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.03 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
3.52 | 18161513 18702808 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
4.15 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
6.71 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.71 | 18569708 20869020 18816296 18520028 20464547 6695378 20135361 20064080 17053015 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
6.71 | 8781369 3148597 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
6.71 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.71 | 11884234 19555203 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.91 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
10.38 | 11408345 11807958 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
10.38 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
10.38 | 11731420 19196723 14580682 16827153 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
13.24 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
13.24 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.89 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.34 | 15990972 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.96 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.27 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.64 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.18 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.53 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.53 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.58 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.55 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.99 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.99 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.17 | 19200415 19189210 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.89 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.62 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.38 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.89 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.89 | 14600291 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
4.09 | 16761898 7688884 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.97 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
4.97 | 17393432 16525653 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.80 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.71 | 11605937 12224865 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.91 | 15727166 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.32 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.34 | 11399792 11118676 11222880 11896295 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.99 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.48 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.48 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.48 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
10.05 | 15861022 16919318 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
10.05 | 18058305 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.26 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
2.96 | 17894541 10334151 17266442 17720292 17620002 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.43 | 19058328 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.80 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.89 | 18045962 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.74 | 16961503 12880345 15451306 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.63 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.63 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
12.15 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
12.15 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
11.39 | 15862959 16503802 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
11.39 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.27 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.74 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.25 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.86 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.13 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.13 | 16712894 8653321 17572228 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.42 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.16 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.65 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.62 | 17120751 |